🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to compare the two imaging modalities perfusion wei...
Status
Unknown
Location
University Hospital Munich, Department of Neurosurgery
Start Date
2008-06
Trial ID
NCT01089244
This phase II trial studies how well fluorine F 18 fluorodopa (18F-DOPA)-po...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2013-12
Trial ID
NCT01991977
This phase I/II trial is studying the side effects and best dose of cediran...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2008-04
Trial ID
NCT00662506
Treatments Being Tested
This research study is exploring how the blood vessels in the participant's...
Status
Completed
Location
Massachuesett General Hospital
Start Date
2013-11
Trial ID
NCT01987830
This early phase I trial tests the safety, side effects and how well medica...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-08-12
Trial ID
NCT07025226
The researchers are doing this study to find out whether the radiopharmaceu...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-10-27
Trial ID
NCT07223034
Treatments Being Tested
This phase II trial studies how well fluorodopa F 18-positron emission tomo...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2019-03-28
Trial ID
NCT03778294
The main purpose of this clinical trial is to find out if cilengitide has a...
Status
Terminated
Location
Merck KGaA Communication Center located in
Start Date
2012-08
Trial ID
NCT01558687
Treatments Being Tested
The aim of this study is to establish FET-PET as an additional therapy asse...
Status
Completed
Location
Department of Stereotactic Neurosurgery
Start Date
2007-01
Trial ID
NCT01089868
This phase III trial tests how well the addition of dinutuximab to Inductio...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2024-04-19
Trial ID
NCT06172296
Treatments Being Tested